Patterson 12:00-1:00 PM Lunch PolyOne Corporation Page 7 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • 18 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Continue specialty transformation • Targeting $2.50 adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth PolyOne Corporation Page 8 Specialty 54% PP&S 18% Distribution 28% 2013 Revenues: $3.8 Billion 2013 Revenues: $3.8 Billion United States 67% Europe 14% Canada 7% Asia 6% Latin America 6% $13 $31 $46 $46 $92 $96 $122 $195 $0 $50 $100 $150 $200 2006 2007 2008 2009 2010 2011 2012 2013 End Markets Specialty Operating Income PolyOne At a Glance Building & Construction 13% Industrial 12% Transportation 18% Wire & Cable 9% Packaging 16% Consumer 10% HealthCare 11% Appliance 6% Electronics & Electrical 5% PolyOne Corporation Page 9 Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 64% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 Q1 2014 2015 % o f O p e ra ti n g I n c o m e * JV's Performance Products & Solutions Distribution Specialty 65-75% Specialty OI $5M $46M $87M $195M $60M Target Mix Shift Highlights Specialty Transformation 2015 Target PolyOne Corporation Page 10 Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence PolyOne Corporation Page 11 -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% 450.00% 550.00% PolyOne S&P 500 Strategy and Execution Drive Results $0.12 $0.27 $0.21 $0.13 $0.68 $0.82 $1.00 $1.31 '06 '07 '08 '09 '10 '11 '12 '13 ‘06-‘13 EPS CAGR = 41% EPS Share Price vs. Richardson Executive Vice President, Chief Financial Officer PolyOne Corporation Page 15 Track Record of Accelerated Growth Total Revenue Adjusted EPS Adjusted EBITDA $2,061 $2,506 $2,709 $2,861 $3,771 2009 2010 2011 2012 2013 ($ in millions, except EPS ) $105 $179 $202 $255 $344 2009 2010 2011 2012 2013 $0.13 $0.68 $0.82 $1.00 $1.31 2009 2010 2011 2012 2013 PolyOne Corporation Page 16 $0.31 $0.44 $0.20 $0.30 $0.40 Q1 2013 Q1 2014 Adjusted EPS $42 $60 $20 $40 $60 Q1 2013 Q1 2014 Specialty Operating Income ($ millions) Q1 2014 Financial Highlights  Growth momentum accelerates driven by specialty platform  Specialty segments and Distribution achieve record results  All segments increase operating income compared to prior year  Revenue grew 25% versus Q1 2013 +43% +42% $57 $79 $30 $60 $90 Q1 2013 Q1 2014 Adjusted Operating Income ($ millions) +39% PolyOne Corporation Page 17 Commitment to Operational Excellence 81% 96% 2006 2013 16.2% 10.9% 2006 2013 On-Time Delivery Working Capital % of Sales 5.0% 31.0% 2006 2013 Percent of Associates Trained in LSS  Three consecutive years – CFO Magazine Best Working Capital Management Program in the chemical industry World’s Best Business Process Excellence Program in 2012*  95 certified Black Belts  211 certified Green Belts  422 Project Leaders World’s Best “Start-up Program” for Lean Six Sigma Deployment in 2009* *Both awards received from International Quality and Productivity Center PolyOne Corporation Page 18 Debt Maturities & Pension Funding – 3/31/14 Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% *TTM 12/31/2013 ** includes US-qualified pension plans only 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of March 31, 2014 PolyOne Corporation Page 19 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend  Expanding our sales, marketing, and technical capabilities  Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.4 million shares in Q1 2014  Repurchased 6.4 million shares since April 2013  13.6 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture)  Manufacturing alignment PolyOne Corporation Page 20 3.07 3.05 1.81 1.45 1.82 1.54 0.85 3.15 1.17 1.69 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.91 PolyOne Valuation Aspirations PEG Ratio Comparison Represents $38 of share price upside Avg = 1.96 PolyOne Corporation Page 21 Innovating for the Future Dr. Patterson President and Chief Executive Officer PolyOne Corporation Page 36 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 37 Innovation Drives Earnings Growth $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 PolyOne Corporation Page 38 Formula for Success Innovation Market Beating Performance Excellence in Execution PolyOne Corporation Page 39 Track Record of Successful Integrations and Rapid Operating Income Growth $12 $44 2007 2013 $22 $30 2012 2013 $24 $49 2012 2013 GLS ColorMatrix Spartech OI in $ millions PolyOne Corporation Page 40 2015 and Beyond Innovation will drive the next stage in our remarkable transformation Deliver on 2015 goals Expand Specialty offerings and possibilities Identified as a truly global, specialty chemical company Market Potential Exceeds $40 Billion PolyOne Corporation Page 41 Driving Toward Premier Profitability EBIT Margins for top tier companies Victrex 42% Sigma Aldrich 18% FMC 25% IFF 18% Eastman 17% Hexcel 16% 16% Rockwood Holdings Celanese 14% 7% EBIT Margin – 2013 Albemarle 24% Ecolab 13% PolyOne Corporation Page 42 Bright Future & High Aspirations – The Next Seven Years • % OP Income from Specialty - 5% • Market Cap - $500 Million • Revenue - $2.6 Billion • Commodity Peers • Specialty ROS - 1.5% • % OP Income from Specialty - 62% • Market Cap - $3.5 Billion • Revenue - $3.7 Billion • Specialty ROS - 9.4% • % OP Income from Specialty - 80 to 90% • Market Cap - $12 to $18 Billion • Revenue - $8 to $10 Billion • Specialty Peers • Specialty ROS - ≥ 20% 2000 – 2006 2007 – 2013 2014 – 2020 PolyOne Corporation Page 43 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

Catering oem C AT E R I N G O E M F O O D T R A Y S • FDA approval for food contact • Specific color • Must be able to withstand high heat/sanitization • Offered the specific desired color • Food contact grade • Customizable high-performance solution able to withstand multiple cleaning cycles with detergents • Provided commercial, technical, and operational excellence support Colorant Chromatics PES Green Color- Concentrate KEY REQUIREMENTS WHY AVIENT?

AVIENT SOLUTION MEDICAL DEVICE MANUFACTURER C O M P R E S S I O N C O N T R O L L E R H O U S I N G G R I P • Good adhesion to PCTG • Comfortable grip combined with ergonomics • Medical regulation compliance • Provided a medical-grade TPE with excellent bonding to PCTG and good chemical resistance • Improved ergonomics and aesthetics with a soft- touch material • Met medical regulation compliance: FDA21 CFR 177.2600 • Delivered good colorability to ensure a stable esthetic KEY REQUIREMENTS OVERMOLDING + REGULATORY SUPPORT LEARN MORE Versollan Thermoplastic Elastomers Copyright © 2024, Avient Corporation.

LEADING EV MANUFACTURER S E A T B E L T T E T H E R C O V E R • Good abrasion resistance • Excellent weather resistance • Nice flexibility and elasticity • Offered a TPE that withstood mechanical stress and friction, helping to prolong the lifespan of the cover • Delivered good resistance to various environmental factors such as UV radiation, moisture, and extreme temperatures • Provided a solution easily processed and molded using standard thermoplastic processing techniques Versaflex Thermoplastic Elastomers KEY REQUIREMENTS WHY AVIENT?

Cosmetic packaging manufacturer COSMETIC PACKAGING MANUFACTURER L I P G L O S S T U B E T I P • Excellent clarity and high fluidity • FDA thermoplastic elastomer • Overmolds to PE as good sealing performance • Met customer’s design requirements, such as a skin-like feel • Offered transparent appearance • Met FDA 21 compliance • Overmolded onto PE compared with silicone OnFlex Thermoplastic Elastomers KEY REQUIREMENTS WHY AVIENT?

SWIMMING POOL CLEANER OEM C L E A N E R C O N N E C T O R • Durable and will not rust • Dimensional stability • Easy to process • Delivered a corrosion-resistant, long glass fiber-reinforced material with excellent strength and modulus to replace steel • Offered low moisture absorption and good chemical resistance to maintain performance • Responded quickly and provided local technology support on mold design and injection process OnForce Long Glass Fiber Nylon Composite KEY REQUIREMENTS WHY AVIENT?

MAJOR TIER 1 SUPPLIER C O N N E C T O R C O V E R • EMI-shielding performance at frequencies from 30 MHz up to 2 GHz • Excellent dimensional stability • Must meet robust mechanical property targets including tensile strength and elongation at break • Worked in close collaboration with the OEM from the start of the development process in order to fully understand their key requirements • Developed a customized material providing the required EMI-shielding performance which, removing the need for secondary metallization manufacturing processes, reduced cycle time Surround™ NN- 14 NICF SIP Black Formulation KEY REQUIREMENTS WHY AVIENT?

HEALTHCARE DEVICE OEM S U R G I C A L S T A P L E R H O U S I N G • Easy-to-mold, durable, and good aesthetics • Excellent disinfection performance and good chemical resistance • Compatible with high- and low-temperature sterilization • Delivered durable and aesthetically pleasing specialty polymer with the added benefit of processing flexibility without retooling • Passed physical, chemical and disinfection tests in different testing conditions which proved good tensile strength and chemical resistance • Achieved consistent molding shape and properties Trilliant™ HC Thermoplastics KEY REQUIREMENTS WHY AVIENT?

DIFAS T O O T H B R U S H H A N D L E • Replace current polymer with a more sustainable solution • Excellent surface finish with multiple color options • Processed using current molding equipment and machinery • Used formulation expertise to develop a custom formulation that met critical quality parameters and enabled customer to use existing molding equipment • Enabled customer to work towards sustainability goals and bring a competitive solution to the market • Enhanced the marketplace appeal of the end product with colorability of the material Maxxam BIO Bio-based Polyolefin Formulations KEY REQUIREMENTS WHY AVIENT?

LUXURY CLOSURE MANUFACTURER S P I R I T B O T T L E C A P D I S K • Specific gravity of 2.6 to match incumbent metal weight • Polypropylene-based material suitable for physical vapor deposition (PVD) surface treatment • Provided an easy-to-process material with an excellent surface finish for metallization • Met custom weight target and used a magnetic filler to support the magnetic system in the PVD metallization process • Enabled more design freedom by eliminating metal working Gravi-Tech™ Density Modified Formulation KEY REQUIREMENTS WHY AVIENT?